Literature DB >> 28943408

Epidemiology of transmissible diseases: Array hybridization and next generation sequencing as universal nucleic acid-mediated typing tools.

W Michael Dunne1, Hannes Pouseele2, Stefan Monecke3, Ralf Ehricht4, Alex van Belkum5.   

Abstract

The magnitude of interest in the epidemiology of transmissible human diseases is reflected in the vast number of tools and methods developed recently with the expressed purpose to characterize and track evolutionary changes that occur in agents of these diseases over time. Within the past decade a new suite of such tools has become available with the emergence of the so-called "omics" technologies. Among these, two are exponents of the ongoing genomic revolution. Firstly, high-density nucleic acid probe arrays have been proposed and developed using various chemical and physical approaches. Via hybridization-mediated detection of entire genes or genetic polymorphisms in such genes and intergenic regions these so called "DNA chips" have been successfully applied for distinguishing very closely related microbial species and strains. Second and even more phenomenal, next generation sequencing (NGS) has facilitated the assessment of the complete nucleotide sequence of entire microbial genomes. This technology currently provides the most detailed level of bacterial genotyping and hence allows for the resolution of microbial spread and short-term evolution in minute detail. We will here review the very recent history of these two technologies, sketch their usefulness in the elucidation of the spread and epidemiology of mostly hospital-acquired infections and discuss future developments.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Array hybridization; Epidemiology; Evolution; Genetic variation; Hospital acquired infection (HAI); Next generation sequencing (NGS)

Mesh:

Year:  2017        PMID: 28943408     DOI: 10.1016/j.meegid.2017.09.019

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  5 in total

Review 1.  Epidemiological aspects of healthcare-associated infections and microbial genomics.

Authors:  C Mirande; I Bizine; A Giannetti; N Picot; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-17       Impact factor: 3.267

2.  Molecular Characterization and Comparative Genomics of Clinical Hybrid Shiga Toxin-Producing and Enterotoxigenic Escherichia coli (STEC/ETEC) Strains in Sweden.

Authors:  Xiangning Bai; Ji Zhang; Anoop Ambikan; Cecilia Jernberg; Ralf Ehricht; Flemming Scheutz; Yanwen Xiong; Andreas Matussek
Journal:  Sci Rep       Date:  2019-04-04       Impact factor: 4.379

3.  Routine Whole-Genome Sequencing for Outbreak Investigations of Staphylococcus aureus in a National Reference Center.

Authors:  Geraldine Durand; Fabien Javerliat; Michèle Bes; Jean-Baptiste Veyrieras; Ghislaine Guigon; Nathalie Mugnier; Stéphane Schicklin; Gaël Kaneko; Emmanuelle Santiago-Allexant; Coralie Bouchiat; Patrícia Martins-Simões; Frederic Laurent; Alex Van Belkum; François Vandenesch; Anne Tristan
Journal:  Front Microbiol       Date:  2018-03-20       Impact factor: 5.640

4.  Antimicrobial resistance in Enterobacteriaceae from healthy broilers in Egypt: emergence of colistin-resistant and extended-spectrum β-lactamase-producing Escherichia coli.

Authors:  Amira A Moawad; Helmut Hotzel; Heinrich Neubauer; Ralf Ehricht; Stefan Monecke; Herbert Tomaso; Hafez M Hafez; Uwe Roesler; Hosny El-Adawy
Journal:  Gut Pathog       Date:  2018-09-19       Impact factor: 4.181

5.  Plethora of Resistance Genes in Carbapenem-Resistant Gram-Negative Bacteria in Greece: No End to a Continuous Genetic Evolution.

Authors:  Katerina Tsilipounidaki; Zoi Athanasakopoulou; Elke Müller; Sindy Burgold-Voigt; Zoi Florou; Sascha D Braun; Stefan Monecke; Nikolaos K Gatselis; Kalliopi Zachou; Aggelos Stefos; Ilias Tsagalas; Marina Sofia; Vassiliki Spyrou; Charalambos Billinis; George N Dalekos; Ralf Ehricht; Efthymia Petinaki
Journal:  Microorganisms       Date:  2022-01-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.